There are 2789 resources available
1166P - Determinants of clinical and pathological stage discordance in resected NSCLC patients: A retrospective observational cohort study
Presenter: Evangeline Samuel
Session: ePoster Display
1167P - DIO2 is implicated in the antitumor effect of the lung embryonic stem cell conditioned medium and impacts prognosis in non-small cell lung cancer
Presenter: Jordi Canals
Session: ePoster Display
1168P - Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)
Presenter: Fernando Fabio Franco
Session: ePoster Display
1126P - Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany
Presenter: Michael Lux
Session: ePoster Display
1149P - An automated platform for rapid drug screening in patient-derived micro-organospheres
Presenter: Zhaohui Wang
Session: ePoster Display
1222P - A blood-based DNA methylation risk score (RS) for predicting the prognosis of EGFR mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC) after first-line TKI treatment
Presenter: Dongsheng Shi
Session: ePoster Display
1110P - COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey
Presenter: Jorge Hernando
Session: ePoster Display
1111P - New prognostic frontiers for lung neuroendocrine tumors: An Italian-Spanish multicentric study of 200 cases
Presenter: Anna La Salvia
Session: ePoster Display
1112P - Modified TGR: A new strong radiological marker to accurately predict early response to PRRT in GEPNETs
Presenter: Federica Scalorbi
Session: ePoster Display